HRT Financial’s Purple Biotech PPBT Stock Holding History

HRT Financial’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-69	Closed	-$5K	–	2982
2024 Q2	$5K	Buy	+69	New	+$8K	﹤0.01%	2042

Other funds holding PPBT

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

GRP

Global Retirement Partners San Rafael, California $5.64B AUM

NSIM

North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return

HRT Financial's PPBT Position: Q3 2024 in Review

HRT Financial sold out of Purple Biotech (PPBT) in Q3 2024, closing a stake of 69 shares — an estimated $5K sold.

HRT Financial first reported a position in PPBT in Q2 2024 and held it in 1 quarter. The position peaked at $5K in Q2 2024. 10 funds tracked by Wall St. Rank hold PPBT as of Q3 2024.

HRT Financial reported no remaining Purple Biotech position as of Q3 2024 after selling out during the quarter.
HRT Financial sold 69 Purple Biotech shares in Q3 2024, an estimated $5K.
HRT Financial first reported a position in Purple Biotech in Q2 2024 and held it in 1 quarter.
HRT Financial's Purple Biotech position peaked at $5K in Q2 2024.
10 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2024.

Based on HRT Financial's 13F filing for Q3 2024, filed 12 Nov 2024.